Digital CNS leadership P1vital offers an integrated eCOA platform with neuropsychology based digital health technology designed to modernize CNS clinical trials, presenting an overarching value proposition to sponsors seeking a one-stop solution across all trial phases.

Validated measures In addition to subjective assessments, P1vital provides validated objective measures, including a Facial Expression Recognition Task used in over 45 clinical trials, enabling more robust endpoints and potentially faster trial outcomes.

Cross-therapeutic scalability The eCOA platform is touted as easily deployable beyond CNS, offering potential expansion into other therapeutic areas and an opportunity to upsell to existing customers seeking broader digital trial capabilities.

Collaborative momentum Recent collaboration with the University of Oxford on mental health studies enhances credibility and opens doors for co-developed studies and joint marketing with top-tier research institutions.

Resource-constrained entry With a small team and modest revenue, P1vital may be an attractive partner for sponsors seeking agile, cost-effective digital trial solutions, and there is room to scale services and cross-sell adjacent digital health offerings.